Results 191 to 200 of about 295,121 (236)

Toxicity outcomes in phase 1 lymphoma trials abstracts are under-reported, with high use of minimizing language. [PDF]

Hemasphere
Maclean M, Waters N, Swan D, Martynchyk A, Smith C, Vickers D, Lee D, Chong G, Hawkes EA.   +8 more
europepmc   +1 more source

Robust Electrocaloric Performance Enabled by Highly‐Polar Frustrated Nanodomains in NaNbO3‐Based Ferrodistortive Relaxor

Advanced Functional Materials, EarlyView.
P4bm framework in NaNbO3‐Ba(Ti, Hf)O3 ferrodistortive relaxor entails short‐range and highly‐polar ferrodistortive orders. The abundant highly‐polar orders facilitate to increase entropy change, and robust octahedral oxygen tilt enables to impede thermal perturbations.
Feng Li, Changshun Dai, He Qi, Jiecheng Liu, Xiaoming Shi, Heng Zhou, Qiong Yang, Mingsheng Long, Lei Shan, Chunchang Wang, Jianli Wang, Zhenxiang Cheng   +11 more
wiley   +1 more source

Awareness of sustainability among gynecologists in Germany: results of a semirepresentative nationwide survey. [PDF]

Arch Gynecol Obstet
Schiestl LJ, Lukac S, Hagedorn C, Ebner F, Bäumer K, Schüler-Toprak S, Schmalfeldt B, Hasenburg A.   +7 more
europepmc   +1 more source

Swelling‐Programmed Topographical Guidance for Dynamic Spheroid Self‐Assembly via a Mechanochemical Hydrogel Niche

Advanced Functional Materials, EarlyView.
A swelling‐programmed micropatterned hydrogel guides adherent cells through a controlled transition from cell–matrix anchoring to cadherin‐mediated cell–cell compaction, enabling rapid assembly of high‐viability spheroids with defined size and morphology.
Han Gyeol Nam, Seon Yeong Chae, Young Woo Kwon, Hye Jin Heo, Hye Rin Lee, Ji Hyeok Lee, Dong‐Wook Han, Yun Hak Kim, Suck Won Hong   +8 more
wiley   +1 more source

The CARL II cohort: what we did and what came out of it. [PDF]

Chiropr Man Therap
Hartvigsen J, Aspinall S, Downie A, Harsted S, Jenkins H, Marchand AA, McNaughton D, Miller A, Nim C, Nyirö L, Roseen EJ, Young JJ, Weber KA, Wong JJ, Øverås CK, Diana De Carvalho, Adams J.   +16 more
europepmc   +1 more source

Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study. [PDF]

Basic Clin Pharmacol Toxicol
Jungo KT, Boyd CM, Farrell B, McCarthy C.   +3 more
europepmc   +1 more source

Cracking the code: a head-to-head comparison of expert clinicians and artificial intelligence in diagnosing rare diseases. [PDF]

Orphanet J Rare Dis
Sendtner GW, Muecke M, Grigull L, Bender T, Behning C, Schäfer VS.   +5 more
europepmc   +1 more source

Welcoming the Resumption of the <i>Case Conference</i> Section. [PDF]

J Korean Med Sci
Yoo JH.
europepmc   +1 more source

Optimisation in X-ray and molecular imaging 2025-editorial. [PDF]

Radiat Prot Dosimetry
Almén A, Båth M, Bernhardt P, Dustler M, Svalkvist A.   +4 more
europepmc   +1 more source